Suvretta Capital Management, LLC Ambrx Biopharma Inc. Transaction History

Suvretta Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$4.07 - $9.0 $1.77 Million - $3.91 Million	434,097 Added 41.04%	1,491,832 $6.15 Million
Q4 2021 Feb 14, 2022	BUY	$8.11 - $13.91 $1.07 Million - $1.83 Million	131,716 Added 14.22%	1,057,735 $9.55 Million
Q3 2021 Nov 15, 2021	BUY	$13.31 - $22.53 $12.3 Million - $20.9 Million	926,019 New	926,019 $12.5 Million
Q3 2021 Nov 15, 2021	SELL	$13.31 - $22.53 $15.6 Million - $26.3 Million	-1,169,529 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$15.95 - $19.6 $18.7 Million - $22.9 Million	1,169,529 New	1,169,529 $22.9 Million

31.2K

Ticker AMAM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,618,400
Market Cap $1.08B
Description
Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is investigated in various clinical trials for the treatment of breast cancer, gas...

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Suvretta Capital Management, LLC with notifications on news.